首页> 外文OA文献 >PDG20 HEALTHCARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES TREATED WITH HYPOMETHYLATING AGENTS: A SEER-MEDICARE ANALYSIS

【2h】

PDG20 HEALTHCARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES TREATED WITH HYPOMETHYLATING AGENTS: A SEER-MEDICARE ANALYSIS

机译：用低甲基化试剂治疗的骨髓增生综合征患者的PDG20医疗资源利用率和成本：Seer-Medicare分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
E.M. Stein; D. Latremouille-Viau; S. Shi; A. Guerin; E. Wu; G. Bonifacio; X. Cao;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Does Provider Experience Treating Patients (pts) with Myelodysplastic Syndromes (MDS) Explain Duration of Hypomethylating Agent (HMA) Therapy and Overall Survival (OS)? A Large Population-Based Analysis [J] . Zeidan Amer M., Hu Xin, Zhu Weiwei, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：提供者经验是否用骨髓增生综合征（MDS）治疗患者（PTS）解释持续的甲基化剂（HMA）治疗和总存活（OS）？大量基于人口分析
2. The Incidence and Health Care Resource Burden of the Myelodysplastic Syndromes in Patients in Whom Firsta??Line Hypomethylating Agents Fail [J] . Christopher R. Cogle, Sandra E. Kurtin, Tanya G. K. Bentley, The oncologist . 2017,第4期

机译：Firsta®线次甲基化剂失败的患者骨髓增生异常综合征的发病率和医疗保健资源负担
3. The Incidence and Health Care Resource Burden of the Myelodysplastic Syndromes in Patients in Whom First-Line Hypomethylating Agents Fail [J] . Cogle Christopher R., Kurtin Sandra E., Bentley Tanya G. K., The oncologist . 2017,第4期

机译：一线低甲基化试剂失败的患者骨髓增生症的发病率和医疗保健资源负担
4. Acquired Glanzmann Thrombasthenia in a Patient with Myelodysplastic Syndrome [C] . A. Trummer, A. Tiede, R. Eisert Hemophilia Symposium . 2008

机译：在患有髓细胞增强综合征的患者中获得了Glanzmann血栓血管瘤
5. Hospital resource utilization among patients with chronic obstructive pulmonary disease—An analysis of 2002–2005 Healthcare Cost and Utilization Project data [D] . Rane, Pallavi B. 2010

机译：慢性阻塞性肺疾病患者的医院资源利用——2002-2005年医疗费用与利用项目数据分析
6. The Incidence and Health Care Resource Burden of the Myelodysplastic Syndromes in Patients in Whom First‐Line Hypomethylating Agents Fail [O] . Christopher R. Cogle, *, Sandra E. Kurtin, 2017

机译：一线次甲基化剂失败的患者骨髓增生异常综合征的发病率和医疗保健资源负担
7. PCN115 Patterns of Care in Patients With Myelodysplastic Syndromes Treated With Hypomethylating Agents [O] . Faria C., Chang E., Powers A., 2012

机译：用次甲基化剂治疗骨髓增生异常综合征患者的PCN115护理方式

PDG20 HEALTHCARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES TREATED WITH HYPOMETHYLATING AGENTS: A SEER-MEDICARE ANALYSIS

著录项

相似文献

相关主题

期刊订阅